<DOC>
	<DOC>NCT00526747</DOC>
	<brief_summary>Our goal of this pilot project is to identify inflammatory biomarkers that correlate with epo-resistance among CKD patients.</brief_summary>
	<brief_title>Erythropoietin Resistance in Anemia of Chronic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>prevalent patients greater than or equal to 18 years old with CKD defined as a glomerular filtration rate &lt; 60 cc/min active GI bleeding or history of GI bleed in the prior 3 months uncontrolled hyperparathyroidism (PTH&gt;500) untreated iron deficiency (transferrin saturation &lt; 20% and ferritin &lt; 100 overt infection active hemolysis hemoglobinopathies known adverse response to erythropoietin prior kidney transplant aluminum toxicity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
</DOC>